While prophylactic surgery is still somewhat controversial, evidence suggests that risk is significantly reduced for women at high risk (Hartmann et al, 1999) and therefore offers hope that their risk of cancer will be reduced despite the presence of the BRCA1/2 mutation. The gene discussed is BRCA1; the disease is cancer.